Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Clinical Laserthermia Systems AB Current Ratio?
Clinical Laserthermia Systems ABFRA:LS60 +0.62%42 Current Ratio is 2.91 as of Mar. 2026, which is 43% above its 10-year median of 2.04. GuruFocus rates FRA:LS60 with a GF Score™ of 42/100 and a GF Value™ of €0.28 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 853 Medical Devices & Instruments companies, Clinical Laserthermia Systems AB ranks better than 56.98% on this metric.
Clinical Laserthermia Systems AB has a current ratio of 2.91. It generally indicates good short-term financial strength.
The historical rank and industry rank for Clinical Laserthermia Systems AB's Current Ratio or its related term are showing as below:
FRA:LS60'
s Current Ratio Range Over the Past 10 Years
Min: 0.27 Med: 2.04 Max: 9.03
Current: 2.91
During the past 13 years, Clinical Laserthermia Systems AB's highest Current Ratio was 9.03. The lowest was 0.27. And the median was 2.04.
FRA:LS60's Current Ratio is ranked better than 56.98% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: 2.49
vs FRA:LS60: 2.91
Clinical Laserthermia Systems AB (FRA:LS60) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Clinical Laserthermia Systems AB Current Ratio Related Terms
Clinical Laserthermia Systems AB Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clinical Laserthermia Systems AB Current Ratio Chart
FRA:LS60 vs ABT, SYK, MDT: Current Ratio Comparison
For the Medical Devices subindustry, Clinical Laserthermia Systems AB's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clinical Laserthermia Systems AB Current Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Clinical Laserthermia Systems AB's Current Ratio distribution charts can be found below:
* The bar in red indicates where Clinical Laserthermia Systems AB's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clinical Laserthermia Systems AB (FRA:LS60) has a Current Ratio of 2.91 as of Mar. 2026. This is 43% above median its historical median of 2.04. Over the past decade, Clinical Laserthermia Systems AB's Current Ratio has ranged from 0.27 to 9.03. According to the industry distribution chart, Clinical Laserthermia Systems AB ranks #367 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 43%.
Is Clinical Laserthermia Systems AB's Current Ratio too high?
Clinical Laserthermia Systems AB's current Current Ratio of 2.91 is 43% above median its 10-year median of 2.04. Over the past 10 years, this metric has ranged from a low of 0.27 to a high of 9.03. The Medical Devices & Instruments industry median Current Ratio is 2.49. Clinical Laserthermia Systems AB's value of 2.91 is 16.9% above this industry median. Based on the distribution chart, Clinical Laserthermia Systems AB ranks #367 out of 853 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Clinical Laserthermia Systems AB has a GF Score™ of 42/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Clinical Laserthermia Systems AB's Current Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Clinical Laserthermia Systems AB ranks #367 out of 853 companies for Current Ratio. This puts Clinical Laserthermia Systems AB in the upper half of its industry. The industry median Current Ratio is 2.49. Clinical Laserthermia Systems AB's value of 2.91 is 16.9% above this benchmark. Historically, Clinical Laserthermia Systems AB's own Current Ratio has ranged from 0.27 to 9.03 over the past decade. While the company's 10-year median is 2.04 vs. the industry median of 2.49, Clinical Laserthermia Systems AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Devices & Instruments company?
The median Current Ratio among Medical Devices & Instruments companies is 2.49, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Clinical Laserthermia Systems AB's current Current Ratio of 2.91 is 16.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median Current Ratio is 2.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Clinical Laserthermia Systems AB's current Current Ratio is 2.91, which is 43% above median its own 10-year median of 2.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clinical Laserthermia Systems AB stock overvalued right now?
Based on GuruFocus' analysis, Clinical Laserthermia Systems AB (FRA:LS60) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.28, compared to a current price of €0.24 — trading 12.9% below its estimated fair value. The current Current Ratio is 2.91, which is 43% above median its 10-year median of 2.04 and 16.9% above the Medical Devices & Instruments industry median of 2.49. Clinical Laserthermia Systems AB's overall GF Score™ is 42/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Clinical Laserthermia Systems AB (FRA:LS60), the current Current Ratio is 2.91 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Clinical Laserthermia Systems AB (FRA:LS60) Overvalued in 2026?
Based on GuruFocus' analysis, Clinical Laserthermia Systems AB stock appears to be undervalued.
The current stock price of €0.24 is trading 12.9% below its estimated GF Value™ of €0.28.
GuruFocus considers Clinical Laserthermia Systems AB to be Modestly Undervalued.
Key valuation signals for FRA:LS60:
Current Ratio: 2.91 (43% above median its 10-year median of 2.04)
GF Value™: €0.28 vs. price of €0.24 (12.9% below fair value)
Industry Position: 16.9% above the Medical Devices & Instruments median (#367 of 853)
No single metric tells the full story. See the FRA:LS60 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Clinical Laserthermia Systems AB Business Description
Clinical Laserthermia Systems AB develops and sells single-use products used during each treatment procedure of treatment of solid tumors cancers. Its products include Thermal Therapy System, Mobile Laser Unit, Laser Applicator Non-cooled and Tissue Temp Probe.
42GF Score
Get the complete analysis for FRA:LS60
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:LS60 has been successfully added to your 
